Cancer

Items 1-10 of 25

Page
per page
Set Descending Direction
  1. CD38 (human) (rec.) (His) (active) (10µg)
    BBL-2275
    BBL-2275-C01010 µg
    CHF 782.00
    CD38 (human) (rec.) (His) (active) (10µg)
  2. CD38 Assay System
    BBL-3031
    BBL-3031-1K1000 assays
    CHF 726.00
    BBL-3031-10K10000 assays
    CHF 2'609.00
    BBL-3031-100K10 x 10000 assaysINQ
    CD38 Assay System
  3. CD40L (human) ELISA Kit
    AG-45B-0018
    AG-45B-0018-KI0196 wells
    CHF 610.00
    CD40L (human) ELISA Kit
  4. ICOSL (B7-H2/CD275) (human) ELISA Kit
    AG-45B-0017
    AG-45B-0017-KI0196 wells
    CHF 610.00
    ICOSL (B7-H2/CD275) (human) ELISA Kit
  5. PARG (human) (rec.) (His) (active) (10µg)
    BBL-2285
    BBL-2285-C01010 µg
    CHF 782.00
    PARG (human) (rec.) (His) (active) (10µg)
  6. PARG (human) (rec.) (His) (active) (1µg)
    BBL-2283
    BBL-2283-C0011 µg
    CHF 441.00
    PARG (human) (rec.) (His) (active) (1µg)
  7. PARG Assay System
    BBL-3033
    BBL-3033-1K1000 assays
    CHF 1'227.00
    BBL-3033-10K10000 assays
    CHF 5'072.00
    BBL-3033-100K10 x 10000 assaysINQ
    PARG Assay System
  8. PD-1 (human) ELISA Kit
    AG-45B-0015
    AG-45B-0015-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  9. PD-L1 (human) ELISA Kit
    AG-45B-0016
    AG-45B-0016-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us

Items 1-10 of 25

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.